ALT FY 2025 Earnings — Altimmune, Inc. Revenue & Financial Results | Market Cap Arena

ALTAltimmune, Inc.

$353M

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$41,000+105.0% YoY

Gross Profit

$00.0% margin

Operating Income

-$94M-230461.0% margin

Net Income

-$88M-214861.0% margin

EPS (Diluted)

$-1.00

Cash Flow

Operating Cash Flow

-$68M

Free Cash Flow

-$68M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$280M

Total Liabilities

$55M

Stockholders' Equity

$225M

Cash & Equivalents

$44M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$41,000	$20,000	+105.0%
Gross Profit	$0	$20,000	-100.0%
Operating Income	-$94M	-$103M	+8.4%
Net Income	-$88M	-$95M	+7.3%